Brand Name | Status | Last Update |
---|---|---|
aminosyn ii | New Drug Application | 2022-05-04 |
aminosyn-pf | New Drug Application | 2022-07-21 |
clinisol | ANDA | 2018-06-01 |
kabiven | New Drug Application | 2023-08-02 |
perikabiven | New Drug Application | 2023-08-07 |
plenamine | ANDA | 2023-04-21 |
premasol - sulfite-free (amino acid) | ANDA | 2022-08-04 |
prosol | New Drug Application | 2020-10-07 |
trophamine | New Drug Application | 2023-11-27 |
Drug common name | D-glutamate |
INN | — |
Description | D-glutamic acid is an optically active form of glutamic acid having D-configuration. It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a D-alpha-amino acid and a glutamic acid. It is a conjugate acid of a D-glutamate(1-). It is an enantiomer of a L-glutamic acid. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | N[C@H](CCC(=O)O)C(=O)O |
PDB | — |
CAS-ID | 6893-26-1 |
RxCUI | — |
ChEMBL ID | CHEMBL76232 |
ChEBI ID | 15966 |
PubChem CID | 23327 |
DrugBank | DB02517 |
UNII ID | — |